IBDEI0GO ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8063,1,4,0)
 ;;=4^374.50
 ;;^UTILITY(U,$J,358.3,8063,2)
 ;;=^269106
 ;;^UTILITY(U,$J,358.3,8064,0)
 ;;=374.52^^52^577^34
 ;;^UTILITY(U,$J,358.3,8064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8064,1,3,0)
 ;;=3^Eyelid Hyperpigmentation
 ;;^UTILITY(U,$J,358.3,8064,1,4,0)
 ;;=4^374.52
 ;;^UTILITY(U,$J,358.3,8064,2)
 ;;=^269108
 ;;^UTILITY(U,$J,358.3,8065,0)
 ;;=374.53^^52^577^36
 ;;^UTILITY(U,$J,358.3,8065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8065,1,3,0)
 ;;=3^Eyelid Hypopigmentation
 ;;^UTILITY(U,$J,358.3,8065,1,4,0)
 ;;=4^374.53
 ;;^UTILITY(U,$J,358.3,8065,2)
 ;;=^269109
 ;;^UTILITY(U,$J,358.3,8066,0)
 ;;=374.54^^52^577^35
 ;;^UTILITY(U,$J,358.3,8066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8066,1,3,0)
 ;;=3^Eyelid Hypertrichosis
 ;;^UTILITY(U,$J,358.3,8066,1,4,0)
 ;;=4^374.54
 ;;^UTILITY(U,$J,358.3,8066,2)
 ;;=^269111
 ;;^UTILITY(U,$J,358.3,8067,0)
 ;;=374.56^^52^577^39
 ;;^UTILITY(U,$J,358.3,8067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8067,1,3,0)
 ;;=3^Eyelid Oth Degenerative Skin D/O
 ;;^UTILITY(U,$J,358.3,8067,1,4,0)
 ;;=4^374.56
 ;;^UTILITY(U,$J,358.3,8067,2)
 ;;=^269114
 ;;^UTILITY(U,$J,358.3,8068,0)
 ;;=374.81^^52^577^33
 ;;^UTILITY(U,$J,358.3,8068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8068,1,3,0)
 ;;=3^Eyelid Hemorrhage
 ;;^UTILITY(U,$J,358.3,8068,1,4,0)
 ;;=4^374.81
 ;;^UTILITY(U,$J,358.3,8068,2)
 ;;=^269115
 ;;^UTILITY(U,$J,358.3,8069,0)
 ;;=374.82^^52^577^32
 ;;^UTILITY(U,$J,358.3,8069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8069,1,3,0)
 ;;=3^Eyelid Edema
 ;;^UTILITY(U,$J,358.3,8069,1,4,0)
 ;;=4^374.82
 ;;^UTILITY(U,$J,358.3,8069,2)
 ;;=^276852
 ;;^UTILITY(U,$J,358.3,8070,0)
 ;;=374.85^^52^577^45
 ;;^UTILITY(U,$J,358.3,8070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8070,1,3,0)
 ;;=3^Eyelid Vascular Anomalies
 ;;^UTILITY(U,$J,358.3,8070,1,4,0)
 ;;=4^374.85
 ;;^UTILITY(U,$J,358.3,8070,2)
 ;;=^269120
 ;;^UTILITY(U,$J,358.3,8071,0)
 ;;=374.86^^52^577^38
 ;;^UTILITY(U,$J,358.3,8071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8071,1,3,0)
 ;;=3^Eyelid Oth D/O,Floppy Eyelid Synd
 ;;^UTILITY(U,$J,358.3,8071,1,4,0)
 ;;=4^374.86
 ;;^UTILITY(U,$J,358.3,8071,2)
 ;;=^269121
 ;;^UTILITY(U,$J,358.3,8072,0)
 ;;=376.11^^52^577^89
 ;;^UTILITY(U,$J,358.3,8072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8072,1,3,0)
 ;;=3^Orbit Granuloma/Pseudotumor
 ;;^UTILITY(U,$J,358.3,8072,1,4,0)
 ;;=4^376.11
 ;;^UTILITY(U,$J,358.3,8072,2)
 ;;=^269176
 ;;^UTILITY(U,$J,358.3,8073,0)
 ;;=376.21^^52^577^93
 ;;^UTILITY(U,$J,358.3,8073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8073,1,3,0)
 ;;=3^Orbit Thyrotoxic Exophthalmos
 ;;^UTILITY(U,$J,358.3,8073,1,4,0)
 ;;=4^376.21
 ;;^UTILITY(U,$J,358.3,8073,2)
 ;;=^269181
 ;;^UTILITY(U,$J,358.3,8074,0)
 ;;=376.33^^52^577^83
 ;;^UTILITY(U,$J,358.3,8074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8074,1,3,0)
 ;;=3^Orbit Edema
 ;;^UTILITY(U,$J,358.3,8074,1,4,0)
 ;;=4^376.33
 ;;^UTILITY(U,$J,358.3,8074,2)
 ;;=^269186
 ;;^UTILITY(U,$J,358.3,8075,0)
 ;;=376.40^^52^577^82
 ;;^UTILITY(U,$J,358.3,8075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8075,1,3,0)
 ;;=3^Orbit Deformity,Unspec
 ;;^UTILITY(U,$J,358.3,8075,1,4,0)
 ;;=4^376.40
 ;;^UTILITY(U,$J,358.3,8075,2)
 ;;=^269191
 ;;^UTILITY(U,$J,358.3,8076,0)
 ;;=376.41^^52^577^90
 ;;^UTILITY(U,$J,358.3,8076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8076,1,3,0)
 ;;=3^Orbit Hypertelorism
 ;;^UTILITY(U,$J,358.3,8076,1,4,0)
 ;;=4^376.41
 ;;^UTILITY(U,$J,358.3,8076,2)
 ;;=^269192
 ;;^UTILITY(U,$J,358.3,8077,0)
 ;;=376.43^^52^577^81
 ;;^UTILITY(U,$J,358.3,8077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8077,1,3,0)
 ;;=3^Orbit Deformity d/t Bone Disease
